All conditions to the to the acquisition of SleepX have been satisfied

Boca Raton, Florida, December 1, 2021 (GLOBE NEWSWIRE) — (OTCPINK: APYP) As previously reported, AppYea continues to work diligently to complete the acquisition of SleepX. All conditions to the to the acquisition, including Israeli regulatory approvals, have been satisfied or waived. However, as previously reported in the Company’s report for the quarter ended September 30, 2021, AppYea’s planned reverse stock split of the outstanding common stock and preferred stock is subject to the approval of the Financial Industry Regulatory Authority (FINRA). While implementation of the reverse stock split is not a condition to the acquisition, the Company believes that it is in the best interests of the Company and shareholders to obtain the requisite FINRA approval for the reverse split prior to completing the acquisition. Safe Harbor and Forward-Looking Statements This press release contains forward-looking statements as that term is defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release that are not purely historical are forward-looking statements. Such forwardlooking statements include, among other things, references to novel technologies and methods; our business and product development plans; or market information. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, our ability to raise the additional funding we will need to continue to pursue our business plan and product development plans; the inherent uncertainties associated with developing new products or technologies and operating as a development stage company; our ability to obtain approvals for and commercialize any of our product candidates; competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this press release, and we assume no obligation to update the forwardlooking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. The Company does not undertake any obligation to publicly update any forward looking statement. Neither the Company nor SleepX are subject to the reporting requirements of the Securities and Exchange Commission under the Securities and Exchange Act of 1934 as amended.